₹10.75
■ +0 +0.00%
18 Jul 2026
NSE Listed
Mono Pharmacare Limited (MONOPHARMA)
Volume: 6,000Avg Vol 1W: 3,200Avg Vol 1M: 3,80052W Range:₹9.45₹27.5
Key Ratios
Checked 1h agoMarket Cap₹72 Cr
Current Price₹10.75
Previous Close₹10.75
High / Low (52w)₹27.5 / ₹9.45
Volume6,000
Avg Vol (1W)3,200
Avg Vol (1M)3,800
Stock P/E6.14
Book Value₹17.66
Dividend Yield—
ROE—
ROA—
Revenue (TTM)₹169 Cr
Revenue Growth37.6%
Profit Margin—
Total Debt₹26 Cr
Shares Outstanding—
Face Value—
EPS (TTM)₹1.75
P/B0.61
Debt / Equity1.6
50 DMA₹11.45
200 DMA₹17.09
Day change+0.00%
Price Chart
₹10.75▼ 55.21% · 1Y
2025-07-182026-07-17
20-day avg volume: 4K shares
Pros
- Company is almost debt-free.
- Stock trades below its book value.
Cons
- Revenue fell 73% YoY.
Profit & Loss (Annual)
| Metric | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|
| Revenue | ₹33 Cr | ₹122 Cr | ₹169 Cr |
| EBITDA | ₹2 Cr | ₹6 Cr | ₹8 Cr |
| Net Profit | ₹1 Cr | ₹2 Cr | ₹3 Cr |
| EPS | 0.79 | 1.58 | 1.75 |
Balance Sheet
| Metric | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|
| Total Assets | ₹63 Cr | ₹81 Cr | ₹110 Cr |
| Total Liabilities | ₹49 Cr | ₹53 Cr | ₹79 Cr |
| Equity | ₹14 Cr | ₹28 Cr | ₹31 Cr |
| Total Debt | — | — | — |
Cash Flow
| Metric | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|
| Operating | ₹-40 Cr | ₹-8 Cr | ₹-3 Cr |
| Investing | ₹-1 Cr | ₹0 Cr | ₹0 Cr |
| Financing | ₹41 Cr | ₹8 Cr | ₹5 Cr |
| Free Cash Flow | ₹-40 Cr | ₹-8 Cr | ₹-3 Cr |
Shareholding
Promoter 56.72% Institutions 0% Public 43.28%
Efficiency & Working Capital
ROCE11%
Interest Coverage2.1
Dividend Payout—
Debtor Days91 d
Inventory Days120 d
Payable Days41 d
Cash Conversion Cycle170 d
Working Capital Days211 d
Shareholding Details
As of 2026-03-31
Promoter56.7%
FII0%
DII0%
Institutions0%
Public43.3%
Promoter Pledge0%
No. of Shareholders529
Shareholding Pattern
Quarterly — figures in %. Latest 11 quarters.
| Period | Apr 2023 | Apr 2023 | Aug 2023 | Aug 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Sept 2024 | Mar 2025 | Sept 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Promoters | 81% | 81% | 81% | 81% | 56.7% | 56.7% | 56.7% | 56.7% | 56.7% | 56.7% | 56.7% |
| FIIs | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| DIIs | 19% | 0% | 19% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Public | 0% | 19% | 0% | 19% | 43.3% | 43.3% | 43.3% | 43.3% | 43.3% | 43.3% | 43.3% |
| Promoter Pledge | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| No. of Shareholders | 17 | 17 | 17 | 17 | 621 | 528 | 418 | 463 | 478 | 514 | 529 |
Returns History (ROE / ROCE / ROA)
| Period | ROE | ROCE | ROA | P/E |
|---|---|---|---|---|
| 202503 | — | — | — | — |
Major Shareholders (>1%)
| Name | Category | Stake | Shares |
|---|---|---|---|
| Lakhatariya Panilam | Shareholding of Promoter and Promoter Group | 45.4% | 80,26,761 |
| Supal Panilam Lakhatariya | Shareholding of Promoter and Promoter Group | 11.3% | 19,93,458 |
| Shardaben Shivalal Lakhtaria | Shareholding of Promoter and Promoter Group | 0% | 530 |
| Archit Shah | Shareholding of Promoter and Promoter Group | 0% | 530 |
| Pallaviben Suhasbhai Shah | Shareholding of Promoter and Promoter Group | 0% | 530 |
| Shivlal Gandabhai Lakhtaria | Shareholding of Promoter and Promoter Group | 0% | 530 |
Promoter Pledges
| Holder | Pledged Shares | % of Holding | As of |
|---|---|---|---|
| Shivlal Gandabhai Lakhtaria | 0 | 0% | 2026-03-31 |
| Lakhatariya Panilam | 0 | 0% | 2026-03-31 |
| Supal Panilam Lakhatariya | 0 | 0% | 2026-03-31 |
| Shardaben Shivalal Lakhtaria | 0 | 0% | 2026-03-31 |
| Archit Shah | 0 | 0% | 2026-03-31 |
| Pallaviben Suhasbhai Shah | 0 | 0% | 2026-03-31 |
| Shivlal Gandabhai Lakhtaria | 0 | 0% | 2025-09-30 |
| Lakhatariya Panilam | 0 | 0% | 2025-09-30 |
| Supal Panilam Lakhatariya | 0 | 0% | 2025-09-30 |
| Shardaben Shivalal Lakhtaria | 0 | 0% | 2025-09-30 |
| Archit Shah | 0 | 0% | 2025-09-30 |
| Pallaviben Suhasbhai Shah | 0 | 0% | 2025-09-30 |
Board of Directors
| Name | Designation | Year |
|---|---|---|
| Panilam Lakhatariya | Chairman / Executive Director / M D / Promoter | 2025 |
| Supal Lakhatariya | Executive Director | 2025 |
| Archit Shah | Executive Director | 2025 |
| Chintan Trivedi | Independent Non Exe. Director | 2025 |
| Jitendra Mansukhlal Dasani | Independent Director | 2025 |
| DRASHTI ROHIT CHANDE | Independent Director | 2025 |
| Rahul Joshi | Company Sec. & Compli. Officer | 2025 |
Segments — Product
| Segment | Revenue | Share |
|---|---|---|
| Pharmaceutical items | ₹0 Cr | — |
Segments — Geography
| Region | Revenue | Share |
|---|---|---|
| India | ₹83 Cr | 100% |
Capital Structure (₹ Cr)
| Year | Face Value | Authorised | Issued | Paid-up |
|---|---|---|---|---|
| 2025 | ₹10 | 20 | 18 | 18 |
Corporate Actions
| Type | Date | Value | Remark |
|---|---|---|---|
| forthcoming | 2026-07-16 | Board Meetings | — |
| forthcoming | 2026-07-09 | Board Meetings | — |
Related-Party Transactions (₹ Cr)
| Year | Subsidiaries | Associates | JV | KMP | Others | Total |
|---|---|---|---|---|---|---|
| 2024 | 83 | 0 | 0 | 4 | 75 | 163 |
| 2024 | 0 | 0 | 0 | 4 | 0 | 4 |
| 2024 | 48 | 0 | 0 | 1 | 36 | 84 |
Company Information
🌐 www.monopharmacareltd.com ↗
📍 1A Krinkal Apartment opp, Mahalaxmi Temple Paldi, Ahmedabad, Gujarat, 380007
Technical AnalysisPremium
Technical analysis (Premium)
Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.
More stocks
Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search